MedTrace Logo

Citicoline Effects on Cortical Membrane Structure and Function

NCT02705066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2019-05-23

No results posted yet for this study

Summary

The goal of this project is to determine the effects of 6-week dietary supplementation with one of two doses of citicoline (250 mg/d, 500 mg/d) or placebo on prefrontal cortical membrane dynamics (31P-MRS) and event-related functional activation (fMRI) in healthy middle-aged adults.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Citicoline supplement

DIETARY_SUPPLEMENT

Placebo supplement

Cellulose

Sponsors & Collaborators

  • University of Cincinnati

    collaborator OTHER

  • Kyowa Hakko Bio Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02705066 on ClinicalTrials.gov